Onderzoeker
Sumin Bian
- Disciplines:Laboratoriumgeneeskunde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Andere medische en gezondheidswetenschappen, Medische biotechnologie, Farmaceutica, Ontdekking en evaluatie van geneesmiddelen
Affiliaties
- Therapeutische en Diagnostische Antilichamen (Afdeling)
Lid
Vanaf1 okt 2014 → 31 okt 2018
Publicaties
1 - 10 van 10
- Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases(2018)
Auteurs: Erwin Dreesen, Bram Verstockt, Sumin Bian, Magali de Bruyn, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Pagina's: 1937 - + - Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing(2018)
Auteurs: Bram Verstockt, Sumin Bian, Gert Van Assche, Séverine Vermeire, Ann Gils, Marc Ferrante
Pagina's: 731 - 739 - Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease(2018)
Auteurs: Sumin Bian, Jiadi Lu, Filip Delport, Séverine Vermeire, Dragana Spasic, Jeroen Lammertyn, Ann Gils
Pagina's: 592 - 596 - Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in Patients(2017)
Auteurs: Sumin Bian
Pagina's: 316 - 321 - ANTIBODIES TOWARDS VEDOLIZUMAB APPEAR FROM WEEK 2 ONWARDS AND DISAPPEAR UPON TREATMENT(2017)
Auteurs: Sumin Bian, Ho Tsun Tang, Miet Peeters, Griet Compernolle, Erwin Dreesen, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: S382 - S382 - Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab(2017)
Auteurs: Sumin Bian, Marc Ferrante, Ann Gils
Pagina's: 468 - 474 - Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study(2017)
Auteurs: Sumin Bian, Séverine Vermeire, Gert Van Assche, Ann Gils, Marc Ferrante
Pagina's: 923 - 932 - Antibodies towards vedolizumab appear from week 2 onwards and disappear upon treatment(2017)
Auteurs: Sumin Bian, HT Tang, M Peeters, G Compernolle, Erwin Dreesen, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: S44 - S44 - Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time(2017)
Auteurs: Sumin Bian, Erwin Dreesen, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils
Pagina's: 2202 - 2208 - Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays(2016)
Auteurs: Sumin Bian, Thomas Van Stappen, Jeroen Lammertyn, Séverine Vermeire, Ann Gils
Pagina's: 62 - 67